Cargando…
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
Rare Diseases (RD) are defined by their prevalence in less than 5 in 10,000 of the general population. Considered individually, each RD may seem insignificant, but together they add up to more than 7000 different diseases. Research in RD is not attractive for pharmaceutical companies since it is unl...
Autores principales: | Cuesta, Angel M., Gallardo-Vara, Eunate, Casado-Vela, Juan, Recio-Poveda, Lucía, Botella, Luisa-María, Albiñana, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025921/ https://www.ncbi.nlm.nih.gov/pubmed/35457036 http://dx.doi.org/10.3390/ijms23084217 |
Ejemplares similares
-
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
por: Albiñana, Virginia, et al.
Publicado: (2022) -
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
por: Albiñana, Virginia, et al.
Publicado: (2020) -
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
por: Albiñana, Virginia, et al.
Publicado: (2017) -
A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2
por: Errasti Díaz, Suriel, et al.
Publicado: (2022) -
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
por: González-Rodríguez, Beatriz, et al.
Publicado: (2019)